Skip to content

CVRx, Inc. CVRX Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-2.3%-0.8pp
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-31.5%+23.5pp
Inspire Medical Systems logo
Inspire Medical SystemsINSP
6.5%+4.8pp

Other financials

Income statement

See full
Revenue$14.8M+19.6%
Gross profit$12.9M+24.9%
Operating income-$12.2M+9.5%
Net income-$13.1M+4.7%
EPS (diluted)-$0.50+5.7%

Balance sheet

See full
Cash & equivalents$72.3M-29.6%
Total debt$59.4M+17.8%
Total equity$29.1M-58.0%
Total assets$99.7M-23.0%

Cash flow

See full
Operating cash flow-$12.2M+4.7%
CapEx$122.0K+7.0%
Free cash flow-$12.3M+4.6%

Valuation

See full
Market cap$148.6M-2.9%
Enterprise value$135.69M+25.0%
P/S2.5×-0.3×

Profitability

See full
Gross margin86.2%+2.7pp
Operating margin-84.6%-8.9pp
Net margin-89.1%-7.0pp
FCF margin-68%-8.1pp

Returns & leverage

See full
Return on equity-107%+73.4pp
Debt / equity+1.3×
Current ratio10.2×-4.6×

Where this comes from

Calculated from CVRx, Inc.’s reported figures.

Based on trailing twelve months.

The official record: CVRx, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVRx, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVRx, Inc.'s free cash flow yield?
CVRx, Inc. (CVRX) reported free cash flow yield of -16.1% in Q1 2026.
How has CVRx, Inc.'s free cash flow yield changed year-over-year?
CVRx, Inc.'s free cash flow yield decreased by 23.6% year-over-year, from -13.1% to -16.1%.
What is the long-term trend for CVRx, Inc.'s free cash flow yield?
Over 4 years (2021 to 2025), CVRx, Inc.'s free cash flow yield has grown at a 17.2% compound annual growth rate (CAGR), from -11.6% to -21.9%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.